$MDAI Spectral AI 
Spectral AI is expected to announce top line data results from its 2024 burn study after the holidays and submit its DeepView technology for FDA approval in the first half of 2025.

· Shares Short (11/29/2024) 3.01 million
· Implied Shares Outstanding - 20.28 million
· Float 9.76 million

· 38.72% Held by Insiders
· 14.52% Held by Institutions

· Short Ratio (11/29/2024) 0.95
· Short % of Float (11/29/2024) 26.55%
· Short % of Shares Outstanding (11/29/2024) 15.44%

· 8.2 million owned by the founders and a long term shareholder
· 3.2 million shares owned by institutions

· Currently trading 1.17 times current sales
https://t.co/UxE2vg3dYp